Tirzepatide vs. Semaglutide: Which Weight Loss Medication is Right for You? BodyByBariatrics What is the pipeline for future medications for obesity? International Journal of Obesity Tirzepatide, a dual GIP GLP 1 receptor co agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction Cardiovascular Diabetology Springer Nature Link Cagrilintide, Tirzepatide, and Retatrutide Peptides: Comparing Metabolic Mechanisms Cagrilintide 5mg + Tirzepatide 10mg Injection (15mg)